4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.445 AUD -2.2%
Market Cap: 183m AUD
Have any thoughts about
4DMedical Ltd?
Write Note

4DMedical Ltd
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

4DMedical Ltd
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
4DMedical Ltd
ASX:4DX
Common Shares Outstanding
AU$410.4m
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Common Shares Outstanding
AU$241.2m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
40%
CogState Ltd
ASX:CGS
Common Shares Outstanding
$170.8m
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
6%
Pro Medicus Ltd
ASX:PME
Common Shares Outstanding
AU$104.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Medibio Ltd
ASX:MEB
Common Shares Outstanding
AU$4.5B
CAGR 3-Years
59%
CAGR 5-Years
83%
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Common Shares Outstanding
AU$550.5m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
22%
No Stocks Found

4DMedical Ltd
Glance View

Market Cap
182.6m AUD
Industry
Health Care

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.467 AUD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is 4DMedical Ltd's Common Shares Outstanding?
Common Shares Outstanding
410.4m AUD

Based on the financial report for Jun 30, 2024, 4DMedical Ltd's Common Shares Outstanding amounts to 410.4m AUD.

What is 4DMedical Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
9%

Over the last year, the Common Shares Outstanding growth was 19%. The average annual Common Shares Outstanding growth rates for 4DMedical Ltd have been 12% over the past three years , 9% over the past five years .

Back to Top